Making re-integration…New Zyprexa Olanzapine. Antipsychotic efficacy…Treatment for the control of schizophrenia and related psychoses. Effective in positive and negative symptoms of psychosis. Effective in depressive symptoms associated with schizophrenia and related psychoses. Effective in both acute and long-term management. No blood monitoring required. Low incidence of acute EPS and treatment-emergent dyskinesia, compared with haloperidol. Low potential for drug interactions. Simple once-daily 10mg dosing. Convenient dosing encourage medication compliance.
Abstract
Olanzapine, Eli Lilly Asia Inc, Animated image of 3 people (1 woman, 2 men) standing; a bigger crowd is seen behind them (but blurry).
